Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem Cells

17 Dec 2021

Abstract excerpt

BACKGROUND: Intestinal fibrosis is a serious complication of Crohn's disease. Numerous cell types including intestinal epithelial and mesenchymal cells are implicated in this process, yet studies are hampered by the lack of personalized in vitro models. Human intestinal organoids (HIOs) derived from induced pluripotent stem cells (iPSCs) contain these cell types, and our goal was to determine the feasibility of...

Topics

Join the communities discussing this publication.

Cancer Cells and Metastasis
Inflammatory Bowel Disease
Mesenchymal stem cell research

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 34918082
DOI: 10.1093/ibd/izab292

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Development of a Personalized Intestinal Fibrosis Model Using Human Intestinal Organoids Derived From Induced Pluripotent Stem CellsPMID 34918082Read ↗

Modeling Intestinal Epithelial Response to Interferon-γ in Induced Pluripotent Stem Cell-Derived Human Intestinal OrganoidsSemantic proximity Read ↗

Insights into Modeling Inflammatory Bowel Disease from Stem Cell Derived Intestinal OrganoidsSemantic proximity Read ↗

Development of Physiologically Responsive Human iPSC-Derived Intestinal Epithelium to Study Barrier Dysfunction in IBDSemantic proximity Read ↗

Establishment of an ulcerative colitis model using colon organoids derived from human induced pluripotent stem cellsSemantic proximity Read ↗

Human Intestinal Tissue with Adult Stem Cell Properties Derived from Pluripotent Stem CellsSemantic proximity Read ↗

A Refined Culture System for Human Induced Pluripotent Stem Cell-Derived Intestinal Epithelial OrganoidsSemantic proximity Read ↗

Drug Discovery via Human-Derived Stem Cell OrganoidsSemantic proximity Read ↗

Patient-derived organoids for therapy personalization in inflammatory bowel diseasesSemantic proximity Read ↗

Celiac disease patient derived iPSC–small intestinal epithelial cells are more persistent under cytokine stimuli than healthy control cellsSemantic proximity Read ↗

Intestinal Organoids Generated from Human Pluripotent Stem CellsSemantic proximity Read ↗

Effects of human induced pluripotent stem cell-derived intestinal organoids on colitis-model miceSemantic proximity Read ↗

A Centimeter-Scale, Peristaltic Human Intestinal Organoid with Integrated Neuro-Immune-Vascular Systems Recapitulates Enteritis and Orthotopic Colorectal CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.